| Date | Title | Description |
| 30.04.2024 | Neurolenses Proven to Reduce Headache Symptoms | Report highlights the data from the recently published double-masked, randomized Headache Study. Based on the clinical study data, Neurolenses provide a statistically significant improvement in headache symptoms.
Click here to view full cli... |
| 16.04.2024 | Neurolens + The Chris Wolfe Podcast | Dr. Chris Wolfe and Davis Corley 6-part podcast series
April 16, 2024 12:04:15 PM by Neurolens Marketing.
Listen to Dr. Christopher Wolfe and Neurolens CEO, Davis Corley in this engaging 6-part podcast as they delve into the groundbreaking ... |
| 13.03.2024 | Neurolens Strengthens Leadership for Accelerated Growth and Innovation | Coppell, Texas — On a mission to transform eye care, Neurolens is pleased to announce a strategic leadership restructuring to fuel continued growth and innovation. This positions the company for even greater success in the evolving eyecare ... |
| 04.03.2024 | Neurolenses Demonstrate Significant Headache Relief | A double-masked, randomized, cross-over clinical study shows that patients wearing Neurolenses had improved scores on a validated headache questionnaire
Neurolens has announced the results of a double-masked, crossover peer-reviewed publica... |
| 28.09.2023 | Neurolens Introduces N3 | An immersive, virtual-reality-based measurement and education experience |
| 20.04.2023 | Neurolens Measures Its One Millionth Patient | DALLAS, April 20, 2023 – Neurolens, a company commercializing innovative solutions to optimize vision, announced today that one million patients have been measured on the Neurolens Measurement Device, its cutting-edge eye tracking system th... |
| 12.09.2022 | Neurolens Raises $67M in Funding | Neurolens, a Dallas, TX-based company company commercializing innovative solutions to optimize vision, raised $67M in funding.
The round was led by MVM Partners, with participation from Falcon Vision/KKR, Marshall Wace, and Bluestem Capital... |
| 12.09.2022 | Neurolens Raises $67 Million from MVM Partners, Falcon Vision/KKR, Marshall Wace & Existing Investors | Investment will be used to develop new products and drive adoption |
